Report Detail

1 Introduction 5

  • 1.1 Industry Definition and Research Scope 5
    • 1.1.1 Industry Definition 5
    • 1.1.2 Research Scope 6
  • 1.2 Research Methodology 9
    • 1.2.1 Overview of Market Research Methodology 9
    • 1.2.2 Market Assumption 10
    • 1.2.3 Secondary Data 10
    • 1.2.4 Primary Data 10
    • 1.2.5 Data Filtration and Model Design 12
    • 1.2.6 Market Size/Share Estimation 13
    • 1.2.7 Research Limitations 14
  • 1.3 Executive Summary 15

2 Market Overview and Dynamics 17

  • 2.1 Market Size and Forecast 17
    • 2.1.1 Impact of COVID-19 on the Market 18
  • 2.2 Major Growth Drivers 20
  • 2.3 Market Restraints and Challenges 24
  • 2.4 Emerging Opportunities and Market Trends 27
  • 2.5 Porter’s Fiver Forces Analysis 31

3 Segmentation of Asia Pacific Market by Product Type 35

  • 3.1 Market Overview by Product Type 35
  • 3.2 Implantable Bioelectric Medicine 37
    • 3.2.1 Cardiac Pacemaker 39
    • 3.2.2 Implantable Cardioverter Defibrillators (ICD) 40
    • 3.2.3 Spinal Cord Stimulators 41
    • 3.2.4 Cochlear Implants 42
    • 3.2.5 Deep Brain Stimulators 43
    • 3.2.6 Vagus Nerve Stimulators 44
    • 3.2.7 Sacral Nerve Stimulators 45
    • 3.2.8 Retinal Implants 46
    • 3.2.9 Other Implantable Bioelectric Medicines 47
  • 3.3 Non-invasive Bioelectric Medicine 48
    • 3.3.1 Transcutaneous Electrical Nerve Stimulators 50
    • 3.3.2 Transcranial Magnetic Stimulation (TMS) 51
    • 3.3.3 Pulsed Electromagnetic Field Therapy 52
    • 3.3.4 Other Non-invasive Bioelectric Medicines 53

4 Segmentation of Asia Pacific Market by End User 54

  • 4.1 Market Overview by End User 54
  • 4.2 Hospitals and Clinics 56
  • 4.3 Research Institutes 57
  • 4.4 Individual Users 58

5 Asia-Pacific Market 2019-2030 by Country 59

  • 5.1 Overview of Asia-Pacific Market 59
  • 5.2 Japan 62
  • 5.3 China 65
  • 5.4 Australia 68
  • 5.5 India 70
  • 5.6 South Korea 72
  • 5.7 Rest of APAC Region 74

6 Competitive Landscape 76

  • 6.1 Overview of Key Vendors 76
  • 6.2 New Product Launch, Partnership, Investment, and M&A 81
  • 6.3 Company Profiles 82

Abbott Laboratories 82

    BIOTRONIK SE & Co. KG 84

      Boston Scientific Corporation 85

        Cochlear Limited 86

          electroCore, Inc. 87

            Inspire Medical Systems, Inc. 88

              LivaNova PLC 89

                Medtronic PLC 90

                  NeuroMetrix, Inc 91

                    Nevro Corp. 92

                      Nuvectra Corporation 93

                        OMRON CORPORATION 94

                          Pixium Vision 95

                            Second Sight Medical Products Inc 96

                              SetPoint Medical 97

                                Sonova Holding AG 98

                                  St. Jude Medical, Inc. 99

                                    Stimwave LLC 100

                                      7 Investing in Asia Pacific Market: Risk Assessment and Management 101

                                      • 7.1 Risk Evaluation of Asia Pacific Market 101
                                      • 7.2 Critical Success Factors (CSFs) 104

                                      Related Reports and Products 107

                                      Bioelectric medicines, also known as electroceuticals, are medical devices that are used to restore health in patients. Bioelectric medicines function through neurostimulation and modulation of the nervous systems through electrical impulses. Asia Pacific bioelectric medicine market will grow by 8.4% annually with a total addressable market cap of $64.58 billion over 2020-2030 owing to the growing geriatric population and rising acceptance of bioelectric medicines.
                                      Highlighted with 30 tables and 42 figures, this 107-page report “Asia Pacific Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific bioelectric medicine market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
                                      In-depth qualitative analyses include identification and investigation of the following aspects:
                                      • Market Structure
                                      • Growth Drivers
                                      • Restraints and Challenges
                                      • Emerging Product Trends & Market Opportunities
                                      • Porter’s Fiver Forces
                                      The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific bioelectric medicine market in every aspect of the classification from perspectives of Product Type, End User, and Country.

                                      Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
                                      Implantable Bioelectric Medicine
                                      • Cardiac Pacemaker
                                      • Implantable Cardioverter Defibrillators (ICD)
                                      • Spinal Cord Stimulators (split into Chronic Pain, Failed Back Syndrome (FBSS), Ischemia by application)
                                      • Cochlear Implants
                                      • Deep Brain Stimulators (split into Parkinson’s Disease, Tremor, Depression, Other Deep Brain Stimulation Applications by application)
                                      • Vagus Nerve Stimulators
                                      • Sacral Nerve Stimulators (split into Urinary Incontinence and Fecal Incontinence by application)
                                      • Retinal Implants
                                      • Other Implantable Bioelectric Medicines
                                      Non-invasive Bioelectric Medicine
                                      • Transcutaneous Electrical Nerve Stimulators
                                      • Transcranial Magnetic Stimulation (TMS)
                                      • Pulsed Electromagnetic Field Therapy
                                      • Other Non-invasive Bioelectric Medicines

                                      Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
                                      • Hospitals and Clinics
                                      • Research Institutes
                                      • Individual Users

                                      Geographically, the following national/local markets are fully investigated:
                                      • Japan
                                      • China
                                      • South Korea
                                      • Australia
                                      • India
                                      • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
                                      For each country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product Type and End User over the forecast years are also included.
                                      The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
                                      Specifically, potential risks associated with investing in Asia Pacific bioelectric medicine market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
                                      Key Players (this may not be a complete list and extra companies can be added upon request):
                                      Abbott Laboratories
                                      BIOTRONIK SE & Co. KG
                                      Boston Scientific Corporation
                                      Cochlear Limited
                                      electroCore, Inc.
                                      Inspire Medical Systems, Inc.
                                      LivaNova PLC
                                      Medtronic PLC
                                      NeuroMetrix, Inc
                                      Nevro Corp.
                                      Nuvectra Corporation
                                      OMRON CORPORATION
                                      Pixium Vision
                                      Second Sight Medical Products Inc
                                      SetPoint Medical
                                      Sonova Holding AG
                                      St. Jude Medical, Inc.
                                      Stimwave LLC
                                      (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)


                                      Summary:
                                      Get latest Market Research Reports on Asia Pacific Bioelectric Medicine. Industry analysis & Market Report on Asia Pacific Bioelectric Medicine is a syndicated market report, published as Asia Pacific Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Country: Trend Forecast and Growth Opportunity. It is complete Research Study and Industry Analysis of Asia Pacific Bioelectric Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

                                      Last updated on

                                      REPORT YOU MIGHT BE INTERESTED

                                      Purchase this Report

                                      $2,780.00
                                      $3,700.00
                                      $4,600.00
                                      2,001.60
                                      2,664.00
                                      3,312.00
                                      2,349.10
                                      3,126.50
                                      3,887.00
                                      305,800.00
                                      407,000.00
                                      506,000.00
                                      206,915.40
                                      275,391.00
                                      342,378.00
                                      Credit card Logo

                                      Related Reports


                                      Reason to Buy

                                      Request for Sample of this report